Whitepaper
7 Oct 2021

Choosing the Right API CDMO

PDF 200 kB

COVID-19 has put unprecedented demands on API manufacturers, exemplified by the dramatically increased need for drugs used to manage critical respiratory care patients being placed on mechanical ventilation.
In turn, this sudden requirement to significantly boost production has emphasized the importance of adaptability for API CDMOs to maintain drug supply, with some organizations proving better able than others to handle the pressures of rapid scale up.

Content provided by our supplier

Wavelength Pharmaceuticals

  • IL
  • 2018
    On CPhI since
  • 2
    Certificates
  • 250 - 499
    Employees

Other Content from Wavelength Pharmaceuticals